Archives
-
WRN–MMR Synthetic Lethality in MSI Colorectal Cancer
2026-08-14
The PNAS study identifies a p53/PUMA-dependent apoptotic mechanism behind the selective vulnerability of mismatch repair-deficient, microsatellite-instability colorectal cancers to Werner helicase loss. Its genetic, pharmacological, and xenograft experiments support WRN as a context-specific therapeutic target, particularly in p53-wildtype MSI tumors.
-
O-GlcNAcylation Links Wnt to Bone Formation
2026-08-13
The reference study identifies O-GlcNAcylation as a metabolic and post-translational relay that connects Wnt3a stimulation with aerobic glycolysis and osteoblastogenesis. Its findings place PDK1 stabilization at Ser174 downstream of Wnt-induced O-GlcNAcylation, offering a mechanistic framework for interpreting Wnt-driven bone formation and fracture repair.
-
FITC Goat Anti-Mouse IgG: Oocyte IF Workflow
2026-08-13
Build sensitive immunofluorescence and flow cytometry assays for porcine oocytes with a fluorescein-conjugated secondary antibody optimized for mouse primary antibodies. This practical guide connects O-GlcNAcylation research with fixation, staining, controls, storage, and troubleshooting decisions that improve mitochondrial, cytoskeletal, oxidative-stress, and autophagy readouts.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-08-12
Build sensitive MAVS and antiviral signaling assays with a far-red Cy5 conjugated secondary antibody for ICC, IHC, western blotting, and flow cytometry. This workflow pairs practical optimization, multiplexing guidance, and troubleshooting with the ASB3–MAVS findings reported in the reference study.
-
Idoxuridine: Translational Control of Viral DNA
2026-08-12
A thought-leadership guide to using Idoxuridine as a mechanistically grounded viral DNA synthesis inhibitor, with practical assay design, translational safeguards, and strategic relevance for antiviral research.
-
CCR7–Notch1 Crosstalk Promotes Mammary Cancer Stemness
2026-08-11
Boyle et al. show that CCR7 signaling functionally intersects with Notch1 to maintain stem-like properties in primary MMTV-PyMT mammary cancer cells. The study uses complementary genetic, pharmacological, molecular, and cellular perturbations to support a model in which dual disruption of CCR7 and Notch1 may be more informative than targeting either axis alone.
-
Glabridin–Gold(I) Complex Reprograms Tumor Immunity
2026-08-11
The reference study develops complex 6d by combining an N-heterocyclic carbene gold(I) center with the natural product glabridin to address both tumor-cell immunogenicity and immune suppression. Its findings support dual targeting of thioredoxin reductase and MAPK signaling as a strategy to improve antitumor immune activity in liver cancer, while also identifying important questions about mechanism, model transferability, and combination therapy.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-10
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and selected flow cytometry workflows. It is intended for research use only; the supplied sodium azide-containing formulation should not be applied directly to live-cell assays without buffer exchange and compatibility testing.
-
DAMGO: From MOR Probe to Pain-Circuit Insight
2026-08-09
DAMGO is a selective µ-opioid receptor agonist for resolving receptor-level and circuit-level mechanisms of opioid analgesia, hypersensitivity, and tolerance. This article translates recent mouse findings into practical assay decisions for opioid receptor signaling research and chronic pain research.
-
Sodium Overload, Mitochondrial Failure, and NECSO
2026-08-08
Qiao and colleagues identify mitochondrial energy failure as the mechanistic link between TRPM4-mediated sodium influx and necrosis by sodium overload, or NECSO. Their model connects mitochondrial Na⁺ accumulation and NCLX-dependent Ca²⁺ loss with impaired oxidative phosphorylation, TCA-cycle activity, ATP depletion, Na/K-ATPase failure, swelling, and lysis.
-
iRGD-RBC Membranes Improve Neuroblastoma PDT
2026-08-07
The reference study develops iRGD-functionalized red blood cell membrane vesicles to deliver the photosensitizer TPOR more effectively to neuroblastoma models. Its findings indicate that combining biomimetic circulation properties with tumor-penetrating targeting can improve cellular uptake, apoptosis, migration inhibition, and tumor growth control compared with free TPOR.
-
HyperScript RT SuperMix for qPCR: Reliable cDNA Synthesis in
2026-08-07
HyperScript RT SuperMix for qPCR streamlines high-fidelity cDNA synthesis, even from RNA with complex secondary structures or low-abundance samples. Its advanced enzyme engineering and optimized primer blend make it an indispensable tool for translational cancer research and precision gene expression analysis.
-
ASB3 E3 Ligase Negatively Regulates Antiviral Immunity via M
2026-08-06
This study reveals that the E3 ligase ASB3 suppresses antiviral innate immunity by targeting the MAVS adaptor protein for K48-linked polyubiquitination and proteasomal degradation. The findings provide new mechanistic insight into post-translational regulation of interferon signaling during RNA virus infection, with implications for dissecting host-pathogen interactions and immune modulation strategies.
-
HyperFluor 488 Goat Anti-Mouse IgG: Precision in Immunodetec
2026-08-06
The HyperFluor 488 Goat Anti-Mouse IgG secondary antibody empowers researchers with high-sensitivity, low-background detection in immunofluorescence, flow cytometry, and western blot workflows. Its advanced dye chemistry and affinity purification deliver robust performance, especially in studies dissecting complex neuroepigenetic mechanisms such as m6A-mediated mRNA regulation.
-
Tioconazole in Antifungal Drug Development: Protocols & Pitf
2026-08-05
Tioconazole stands out as a high-purity antifungal medication, optimized for robust modeling of ergosterol biosynthesis inhibition. This guide delivers practical protocols, advanced assay insights, and troubleshooting strategies to maximize reproducibility and translational value in antifungal drug development.